OGT Expands Pre-implantation Genetic Screening Offering with New Embryo Screen Array | GenomeWeb

NEW YORK (GenomeWeb) — Oxford Gene Technology has broadened its activity in the pre-implantation genetic screening market with the launch of a new oligonucleotide microarray.

Called the CytoSure Embry Screen Array, OGT's new chip includes eight, 60,000-spot arrays per slide for high-resolution, genome-wide aneuploidy and copy number detection in pre-implantation embryos. According to the Oxford, UK-based company, the chip can support the high-throughput analysis of 14 embryos per slide using single-color hybridization, making it ideal for use in embryo banking.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.